409 related articles for article (PubMed ID: 26213212)
21. Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.
Taioli E; Ragin C; Wang XH; Chen J; Langevin SM; Brown AR; Gollin SM; Garte S; Sobol RW
BMC Cancer; 2009 Oct; 9():354. PubMed ID: 19807915
[TBL] [Abstract][Full Text] [Related]
22. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
[TBL] [Abstract][Full Text] [Related]
23. Promotor hypermethylated genes: Prospective diagnostic biomarkers in oral cancerogenesis.
Dvojakovska S; Popovic-Monevska D; Grcev A; Pancevski G; Benedetti A; Popovski V; Dimovski A; Stamatoski A
J Craniomaxillofac Surg; 2018 Oct; 46(10):1737-1740. PubMed ID: 30100382
[TBL] [Abstract][Full Text] [Related]
24. Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing.
Kristensen LS; Treppendahl MB; Asmar F; Girkov MS; Nielsen HM; Kjeldsen TE; Ralfkiaer E; Hansen LL; Grønbæk K
Sci Rep; 2013 Sep; 3():2789. PubMed ID: 24071855
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India.
Das M; Sharma SK; Sekhon GS; Saikia BJ; Mahanta J; Phukan RK
Asian Pac J Cancer Prev; 2014; 15(22):9955-60. PubMed ID: 25520135
[TBL] [Abstract][Full Text] [Related]
26. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C
J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
[TBL] [Abstract][Full Text] [Related]
27. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
28. Exclusion of histiocytes/endothelial cells and using endothelial cells as internal reference are crucial for interpretation of MGMT immunohistochemistry in glioblastoma.
Hsu CY; Lin SC; Ho HL; Chang-Chien YC; Hsu SP; Yen YS; Chen MH; Guo WY; Ho DM
Am J Surg Pathol; 2013 Feb; 37(2):264-71. PubMed ID: 23282970
[TBL] [Abstract][Full Text] [Related]
29. DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization.
Padin-Iruegas E; Chamorro-Petronacci CM; Sines-Cajade I; Lorenzo-Pouso AI; Blanco-Carrión A; Pérez-Jardón A; Gándara-Vila P; Pérez-Sayans M
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888599
[No Abstract] [Full Text] [Related]
30. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.
Wang J; Sasco AJ; Fu C; Xue H; Guo G; Hua Z; Zhou Q; Jiang Q; Xu B
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):118-25. PubMed ID: 18199718
[TBL] [Abstract][Full Text] [Related]
31. CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues.
Kupčinskaitė-Noreikienė R; Skiecevičienė J; Jonaitis L; Ugenskienė R; Kupčinskas J; Markelis R; Baltrėnas V; Sakavičius L; Semakina I; Grižas S; Juozaitytė E
Medicina (Kaunas); 2013; 49(8):361-6. PubMed ID: 24509146
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic accuracy of reverse transcription-PCR quantification of cytokeratin mRNA in the detection of sentinel lymph node invasion in oral and oropharyngeal squamous cell carcinoma: a comparison with immunohistochemistry.
Garrel R; Dromard M; Costes V; Barbotte E; Comte F; Gardiner Q; Cartier C; Makeieff M; Crampette L; Guerrier B; Boulle N
Clin Cancer Res; 2006 Apr; 12(8):2498-505. PubMed ID: 16638858
[TBL] [Abstract][Full Text] [Related]
33. [Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application].
Zhong ZJ; Yang JX; Cao DY; Sun Y; Sun LL; Cheng XM; Chen J; Lang JH; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):196-200. PubMed ID: 22781071
[TBL] [Abstract][Full Text] [Related]
34. Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma.
Pasini FS; Maistro S; Snitcovsky I; Barbeta LP; Rotea Mangone FR; Lehn CN; Walder F; Carvalho MB; Brentani MM; Federico MH
Acta Oncol; 2012 Jan; 51(1):77-85. PubMed ID: 21985131
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
36. Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma.
Bhatia V; Goel MM; Makker A; Tewari S; Yadu A; Shilpi P; Kumar S; Agarwal SP; Goel SK
Biomed Res Int; 2014; 2014():248419. PubMed ID: 24991542
[TBL] [Abstract][Full Text] [Related]
37. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].
Fang HL; Yu ZC; Zhu HB; Jin YT
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077
[TBL] [Abstract][Full Text] [Related]
38. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; van der Laan BF; van Criekinge W; de Meyer T; Denil S; Wisman GB; Roodenburg JL; Schuuring E
Genes Chromosomes Cancer; 2016 Jan; 55(1):45-59. PubMed ID: 26391330
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
40. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H
Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
